Astrazeneca PLC, 10% Owner at PhaseBio Pharmaceuticals Inc (PHAS), bought 3,004,554 shares at $5.00 ($3.0M) on 2018-10-22, disclosed to the SEC on 2018-10-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,404,554 | $0 | 0.0% |
| 2 | $5.00 | 600,000 | $3.0M | 100.0% |
| Total | $1.00 avg | 3,004,554 | $3.0M | 100% |
| Filing → |